InspireMD Inc. (NSPR)
InspireMD Statistics
Share Statistics
InspireMD has 30.64M shares outstanding. The number of shares has increased by 18.95% in one year.
| Shares Outstanding | 30.64M |
| Shares Change (YoY) | 18.95% |
| Shares Change (QoQ) | 13.83% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 19.53M |
| Failed to Deliver (FTD) Shares | 163 |
| FTD / Avg. Volume | 0.28% |
Short Selling Information
The latest short interest is 191.93K, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 191.93K |
| Short % of Shares Out | 0.63% |
| Short % of Float | 0.86% |
| Short Ratio (days to cover) | 4.37 |
Valuation Ratios
The PE ratio is 70.82 and the forward PE ratio is -3.5. InspireMD's PEG ratio is -9.68.
| PE Ratio | 70.82 |
| Forward PE | -3.5 |
| PS Ratio | 15.73 |
| Forward PS | 1.6 |
| PB Ratio | 3.06 |
| P/FCF Ratio | -4.74 |
| PEG Ratio | -9.68 |
Enterprise Valuation
InspireMD has an Enterprise Value (EV) of 93.15M.
| EV / Sales | 13.29 |
| EV / EBITDA | -2.78 |
| EV / EBIT | -4.26 |
| EV / FCF | -4 |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.28 |
| Quick Ratio | 4.94 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | -0.05 |
| Debt / FCF | -0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 4.31% and Return on Invested Capital is -82.38%.
| Return on Equity | 4.31% |
| Return on Assets | 3.33% |
| Return on Invested Capital | -82.38% |
| Revenue Per Employee | $82.46K |
| Profits Per Employee | $18.32K |
| Employee Count | 85 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.14 |
Taxes
| Income Tax | 59K |
| Effective Tax Rate | 3.79% |
Stock Price Statistics
The stock price has increased by 28.86% in the last 52 weeks. The beta is 0.74, so InspireMD's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | 28.86% |
| 50-Day Moving Average | 2.77 |
| 200-Day Moving Average | 2.74 |
| Relative Strength Index (RSI) | 49.54 |
| Average Volume (20 Days) | 58.73K |
Income Statement
In the last 12 months, InspireMD had revenue of 7.01M and earned 1.56M in profits. Earnings per share was -0.76.
| Revenue | 7.01M |
| Gross Profit | 1.51M |
| Operating Income | -33.5M |
| Net Income | 1.56M |
| EBITDA | -33.5M |
| EBIT | -33.5M |
| Earnings Per Share (EPS) | -0.76 |
Balance Sheet
The company has 18.92M in cash and 1.8M in debt, giving a net cash position of 17.12M.
| Cash & Cash Equivalents | 18.92M |
| Total Debt | 1.8M |
| Net Cash | 17.12M |
| Retained Earnings | -253.51M |
| Total Assets | 46.81M |
| Working Capital | 32.84M |
Cash Flow
In the last 12 months, operating cash flow was -21.87M and capital expenditures -1.4M, giving a free cash flow of -23.27M.
| Operating Cash Flow | -21.87M |
| Capital Expenditures | -1.4M |
| Free Cash Flow | -23.27M |
| FCF Per Share | -0.55 |
Margins
Gross margin is 21.49%, with operating and profit margins of -478% and 22.21%.
| Gross Margin | 21.49% |
| Operating Margin | -478% |
| Pretax Margin | 22.21% |
| Profit Margin | 22.21% |
| EBITDA Margin | -478% |
| EBIT Margin | -478% |
| FCF Margin | -332% |
Dividends & Yields
NSPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.41% |
| FCF Yield | -21.1% |
Analyst Forecast
The average price target for NSPR is $4.75, which is 83.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.75 |
| Price Target Difference | 83.4% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Apr 27, 2021. It was a backward split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -4.58 |
| Piotroski F-Score | 1 |